REACT(5)ion from Steve Dunn: Feeling conflicted about which P2Y12 inhibitor to use since ISAR-REACT 5 was released? Listen to Steve’s REACT(5)ion here first!
How sweet it is to be an SGLT2 Inhibitor: Listen to Dr. Ted Berei’s thoughts about dapagliflozin use in patients with heart failure and reduced ejection fraction.
Entering the TWILIGHT Zone: In this episode, we’ll talk to Dr. Craig Beavers about his thoughts on the TWILIGHT trial and discuss his aspiring future podcast combining cardiology with pop culture! Anticipated release of 2024…
In Zac Noel we ENTRUST: Double or Nothing?: A few recent trials have evaluated triple antithrombotic therapy vs. dual antithrombotic therapy in patients with ACS/PCI and AF. In this episode, we put our full (en)TRUST in Dr. Zac Noel as he helps us navigate this complex clinical conundrum.
“Been There, Done That”- Expert Advice From Parting RPDs: In this special two-part episode former Cardiology Residency Program Director Tracy Macaulay, interviews Dr. Kerry Pickworth and Dr. Robert Didomenico, former RPDs at Ohio State and University of Illinois at Chicago, respectively. Words of wisdom are pulled from a recently published opinion paper on recommendations for training cardiovascular pharmacy specialists and tricks on finding the right match this recruitment season.